Investigational Drug Service - Rady Childrens Hospital-San Diego, San Diego
University of California, San Diego/ Rady Children's Hospital - San Diego, San Diego

ReclutandoFase 3

Edades de 2 a 11 · Todos los sexos · Actualizado el 5 nov 2026 · NCT06807281

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Anaheim Clinical Trials, LLC, Anaheim
TCR Medical Corporation, San Diego

ReclutandoFase 1Se aceptan voluntarios sanos

Edades de 18 a 70 · Todos los sexos · Actualizado el 5 nov 2026 · NCT06564389

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

Marvel Clinical Research, Huntington Beach
Metropolis Dermatology - DTLA, Los Angeles
Northridge Clinical Trials, Northridge
y 1 más

ReclutandoFase 2

Edades de 18 a 64 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07216027

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

Investigational Site, Fountain Valley
Investigational Site, Los Angeles

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07003425

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

Kern Research, Inc.- Site Number : 8400047, Bakersfield
Center for Dermatology Clinical Research- Site Number : 8400014, Fremont
Dermatology Research Associates - Los Angeles- Site Number : 8400020, Los Angeles
y 4 más

ReclutandoEstudio observacional

Edades de 12 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT07290803

A Study Evaluating TRIV-573 in Atopic Dermatitis

Triveni Bio Site #15, Fountain Valley
Triveni Bio Site #4, Los Angeles

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 28 oct 2026 · NCT07782333

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)

First OC Dermatology, Irvine

ReclutandoFase 1Se aceptan voluntarios sanos

Edades de 18 a 72 · Todos los sexos · Actualizado el 29 sept 2026 · NCT06808477

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

Novartis Investigative Site, Fountain Valley
Novartis Investigative Site, Los Angeles
Novartis Investigative Site, Sacramento
y 2 más

ReclutandoFase 2

Edades de 18 a 100 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06947993

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Enveda Investigative Site, Beverly Hills
Enveda Investigative Site, Fremont
Enveda Investigative Site, San Diego
y 3 más

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07298395

The Impact of Dietary Salt on the Severity of Eczema

San Francisco VA Medical Center, San Francisco
UCSF Mt Zion Campus, San Francisco

ReclutandoFase 4Se aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 sept 2026 · NCT07447063

The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease

UCSF Mt Zion Campus, San Francisco
San Francisco VA Medical Center, San Francisco

ReclutandoFase 4Se aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07487831

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

Marvel Research, LLC, Huntington Beach
Metropolis Dermatology, Los Angeles
Dermatology Research Associates, Los Angeles
y 4 más

ReclutandoFase 2

Edades de 18 a 65 · Todos los sexos · Actualizado el 28 ago 2026 · NCT07599813

Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.

Allergy and Asthma Medical Group and Research Center, San Diego

ReclutandoEstudio observacional

Edades de 12 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT06899204

Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.

Integrative Skin Science and Research, Sacramento

ReclutandoFase 4

Edades de 12 en adelante · Todos los sexos · Actualizado el 13 ago 2026 · NCT07560618

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Inmagene Site 1, Lancaster
Inmagene Site 23, Los Angeles

ReclutandoFase 2

Edades de 18 a 74 · Todos los sexos · Actualizado el 12 ago 2026 · NCT07037901

A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Enveda Investigative Site, Encinitas
Enveda Investigative Site, Los Angeles
Enveda Investigative Site, Northridge

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 ago 2026 · NCT07643766

Sodium in the Skin and Atopic Dermatitis

San Francisco VA Medical Center, San Francisco
UCSF Mt Zion Campus, San Francisco

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 50 en adelante · Todos los sexos · Actualizado el 14 jul 2026 · NCT06998446

Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

University of California, San Diego: Dermatology Clinical Trials Unit, San Diego

ReclutandoFase 1

Edades de 6 en adelante · Todos los sexos · Actualizado el 2 jul 2026 · NCT06504160

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

First OC Dermatology, Fountain Valley
Center for Dermatology Clinical Research, Inc., Fremont
California Allergy and Asthma Medical Group, Los Angeles
y 1 más

ReclutandoFase 2

Edades de 18 a 65 · Todos los sexos · Actualizado el 15 jun 2026 · NCT06397911

Molecular Signatures of Cutaneous Dupilumab Response

University of California, San Francisco, San Francisco

ReclutandoFase 4

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 jun 2026 · NCT05858619

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Galderma Investigational Site - 7074, Corona
Galderma Investigational Site 8636, Fountain Valley
Galderma Investigational Site 8224, Fremont
y 4 más

ReclutandoEstudio observacional

Edades de 12 en adelante · Todos los sexos · Actualizado el 13 mar 2026 · NCT06988605

Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

Corvus Clinical Trials, South San Francisco

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 mar 2026 · NCT07441395

Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT

University of California San Diego (UCSD), La Jolla

ReclutandoEstudio observacional

Todas las edades · Mujeres · Actualizado el 28 ene 2025 · NCT05938478

A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

Physioseq, LLC /ID# 267266, Sacramento

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 24 ene 2025 · NCT06524635

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.